title: [Effects of plasma antithrombin III, fibrinopeptide A during use of oral contraceptives, and antithrombin III inhibitory effect of conjugated estrogen].
authors.forename: H
authors.initials: H
authors.lastname: Ogura
authors.forename: Y
authors.initials: Y
authors.lastname: Katsumi
authors.forename: M
authors.initials: M
authors.lastname: Mishima
authors.forename: M
authors.initials: M
authors.lastname: Yokoyama
authors.forename: A
authors.initials: A
authors.lastname: Iwaki
mesh_terms: D001208:Asia; D001695:Biology; D001769:Blood; D019411:Clinical Laboratory Techniques; D003267:Contraception; D003276:Contraceptives, Oral; D019049:Developed Countries; D003933:Diagnosis; D004703:Endocrine System; D004967:Estrogens; D005193:Family Planning Services; D005202:Asia, Eastern; D006728:Hormones; D007564:Japan; D010827:Physiology
chemical_list: D003276:Contraceptives, Oral; D004967:Estrogens; D006728:Hormones
keywords: Asia; Biology; Contraception; Contraceptive Methods--side effects; Developed Countries; Eastern Asia; Endocrine System; Estrogens--side effects; Examinations And Diagnoses; Family Planning; Hematological Effects--changes; Hemic System; Hormones; Japan; Laboratory Examinations And Diagnoses; Oral Contraceptives--side effects; Physiology